Before the family name meant overdose statistics, it meant museum wings. Empire of Pain, Patrick Radden Keefe’s 2021 chronicle of the Sackler dynasty, opens generations before OxyContin, with Arthur Sackler, a brilliant Brooklyn-born psychiatrist turned advertising savant who essentially invented modern pharmaceutical marketing, selling tranquilizers to postwar America and buying Chinese antiquities at industrial scale. His brothers’ heirs would apply his playbook, doctors courted, pain redefined, addiction concerns dissolved in sales copy, to a time-release opioid launched in 1996, and the book’s long arc runs from Valium’s gilded age to Purdue Pharma’s bankruptcy, tracking how a fortune built on persuasion ended as a byword for the American overdose catastrophe.
Reception installed it immediately among the era’s essential nonfiction, prize-garlanded and permanently recommended, with readers describing a specific experience, a five-hundred-page book consumed with clenched teeth. Praise centers on the archival depth, depositions, internal emails, court exhibits, and on Keefe’s control, a story of maximum outrage told with prosecutorial calm. The recurring reservations are structural, length that some find punishing in the legal-endgame chapters, a third act of settlements and shell maneuvers that repeats because reality repeated, and an ending that can’t deliver the accountability the preceding pages make the reader crave. The fury, readers broadly agree, is the product working as designed.
Three Generations of the Sales Pitch
Its masterstroke is starting early. Arthur Sackler’s chapters function as origin story for an entire industry’s ethics, the medical ad agencies he controlled, the journals he founded, the seeding of doctors with samples and flattery, the Valium campaigns that made a sedative a household staple, and Keefe’s thesis assembles itself quietly, that OxyContin’s marketing was not an aberration but an inheritance, the family business perfected across generations before the product that made it infamous. The antiquities collecting, wings donated with naming rights negotiated like licensing deals, establishes the dynasty’s other addiction, reputation, and sets up the book’s final movement, when the name itself becomes toxic and institutions begin unbolting the letters.
The Purdue chapters convert documentation into indictment. Keefe reconstructs the launch and defense of OxyContin through the company’s own paper, the sales-force training, the invented pseudo-addiction concept deployed when patients showed dependency, the bonus structures aimed at high-prescribing doctors, the pill-mill data the company held while the crisis compounded, and the family board meetings where, the exhibits show, the distance between the Sacklers and the conduct was far thinner than the philanthropy suggested. Richard Sackler emerges as the book’s chilling central figure, his emails, urging blizzards of prescriptions, blaming abusers as the problem, supplying the moments readers quote in disbelief. Against the dynasty, Keefe threads the counter-cast, the small-town doctors and federal prosecutors whose early 2000s case was settled soft after Washington intervention, the activist Nan Goldin staging die-ins under Sackler-named skylights, and the accumulating dead who appear, deliberately, as the ledger the family never once discusses in the record.
Keefe’s control is the craft achievement readers cite most. The material invites screaming, and the book never raises its voice, letting juxtaposition, a deposition’s evasion beside an overdose statistic, a gala beside a bankruptcy filing, do the work, and the result reads like a novelistic saga, ambition, succession, denial, wearing the evidentiary armor of a filing cabinet.
Length, Repetition, and the Missing Verdict
Honest complaints about Empire of Pain are mostly about endurance. At five hundred plus pages, the book’s early Arthur material, essential to the thesis, runs long for readers who arrived for Purdue, and the final act, years of litigation, bankruptcy engineering, and settlement mathematics designed to shield the family fortune, cycles through maneuvers whose sameness is precisely the story and precisely the slog. Some readers describe the last hundred pages as important homework after three hundred pages of propulsion.
A deeper frustration is the one no author could fix. The book ends where reality did, wealth substantially intact, admissions avoided, the name removed from walls but not from trusts, and readers looking for catharsis close the book without it, an anticlimax Keefe frames as the final exhibit, impunity as the system’s feature. A related boundary, the Sacklers declined participation, and the book is built, exhaustively but unavoidably, from documents, litigation, and the accounts of others, with the family’s perspective present mainly as legal statements and the occasional unrepentant interview from the archive. Critics from the family’s corner call the result one-sided. The documentary record, most readers conclude, sided first.
A final note of scope, the crisis’s street-level devastation appears in portraits and numbers but the book remains a boardroom-and-dynasty account, and readers seeking the epidemic from the patient’s side pair it with the era’s addiction memoirs and reportage.
Philanthropy as Laundering, Documented
What elevates Empire of Pain beyond corporate exposé is its subject’s second product line. The Sacklers, the book demonstrates, ran a decades-long parallel campaign converting pharmaceutical profit into cultural immortality, wings, professorships, galleries, the name embossed wherever prestige was sold, and Keefe’s structure makes the two businesses inseparable, reputation management as the dynasty’s true core competency, practiced from Arthur’s first museum gift to the bankruptcy’s final press release. The book’s climactic movement, institutions scrubbing the name as activists and evidence made it unkeepable, plays as the only verdict actually delivered, and its implications outlast the case, a standing audit of how money launders itself through marble. The overdose numbers appear throughout, uninflected, and do more than any adjective could. The family, the book notes, never says them aloud.
Should You Read Empire of Pain?
Read it as the definitive account of the opioid crisis’s authorship and one of the great American dynasty sagas, essential for anyone who wants the catastrophe explained as decisions rather than weather. Pair it with street-level accounts of the epidemic for the full ledger.
Skip it if a long, verdict-less anatomy of impunity will cost you more composure than it returns, a fully legitimate accounting. The book’s fury is slow-release by design, and there is no antidote chapter.
The Verdict on Empire of Pain
Empire of Pain is investigative nonfiction at dynastic scale, three generations of salesmanship traced from tranquilizer ads to bankruptcy court with a documentary rigor that leaves the family’s mythology nowhere to stand. Keefe’s restraint makes the material’s fury land harder, Richard Sackler’s paper trail supplies the era’s coldest villain portrait, and the philanthropy thesis reframes every museum wall it touches. The length is real, the legal-endgame chapters grind, and the missing verdict is history’s failure faithfully transcribed. Pain, the family’s product line insisted, was undertreated. Accountability, this book documents, still is.